1. Pharmacokinetic aspects of theophylline in premature newborns;Aranda;New Engl. J. Med,1976
2. Effects of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity;Beavo;Mol. Pharmacol,1970
3. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3′,5′-monophosphate and guanosine cyclic 3′,5′-monophosphate phosphodiesterase;Bergstrand;Mol. Pharmacol,1971
4. Adenosine 3′,5′-phosphate in biological materials. I. Purification and properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5′-phosphate in human urine;Butcher;J. Biol. Chem.,1962
5. Interaction between isoprenaline and aminophylline in asthma;Campbell;Thorax,1977